117 related articles for article (PubMed ID: 28950392)
1. Systemic Hypoxia Increases the Expression of DPP4 in Preadipocytes of Healthy Human Participants.
Chowdhury HH; Velebit J; Mekjavic IB; Eiken O; Kreft M; Zorec R
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):91-95. PubMed ID: 28950392
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia Alters the Expression of Dipeptidyl Peptidase 4 and Induces Developmental Remodeling of Human Preadipocytes.
Chowdhury HH; Velebit J; Radić N; Frančič V; Kreft M; Zorec R
J Diabetes Res; 2016; 2016():7481470. PubMed ID: 26881257
[TBL] [Abstract][Full Text] [Related]
3. Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes.
Zilleßen P; Celner J; Kretschmann A; Pfeifer A; Racké K; Mayer P
Sci Rep; 2016 Mar; 6():23074. PubMed ID: 26983599
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Lamers D; Famulla S; Wronkowitz N; Hartwig S; Lehr S; Ouwens DM; Eckardt K; Kaufman JM; Ryden M; Müller S; Hanisch FG; Ruige J; Arner P; Sell H; Eckel J
Diabetes; 2011 Jul; 60(7):1917-25. PubMed ID: 21593202
[TBL] [Abstract][Full Text] [Related]
5. Reduced DPP4 activity improves insulin signaling in primary human adipocytes.
Röhrborn D; Brückner J; Sell H; Eckel J
Biochem Biophys Res Commun; 2016 Mar; 471(3):348-54. PubMed ID: 26872429
[TBL] [Abstract][Full Text] [Related]
6. Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells.
Röhrborn D; Eckel J; Sell H
FEBS Lett; 2014 Nov; 588(21):3870-7. PubMed ID: 25217834
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
[TBL] [Abstract][Full Text] [Related]
8. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.
Shiobara T; Chibana K; Watanabe T; Arai R; Horigane Y; Nakamura Y; Hayashi Y; Shimizu Y; Takemasa A; Ishii Y
Respir Res; 2016 Mar; 17():28. PubMed ID: 26975422
[TBL] [Abstract][Full Text] [Related]
12. Significance of circulatory DPP4 activity in metabolic diseases.
Nargis T; Chakrabarti P
IUBMB Life; 2018 Feb; 70(2):112-119. PubMed ID: 29331088
[TBL] [Abstract][Full Text] [Related]
13. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
[TBL] [Abstract][Full Text] [Related]
14. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
[TBL] [Abstract][Full Text] [Related]
15. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.
Moffitt LR; Bilandzic M; Wilson AL; Chen Y; Gorrell MD; Oehler MK; Plebanski M; Stephens AN
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143089
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis.
Barchetta I; Cimini FA; Dule S; Cavallo MG
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140405
[TBL] [Abstract][Full Text] [Related]
18. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
19. Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis.
Schulz K; Frahm J; Kersten S; Meyer U; Rehage J; Piechotta M; Meyerholz M; Breves G; Reiche D; Sauerwein H; Dänicke S
PLoS One; 2015; 10(8):e0136078. PubMed ID: 26291537
[TBL] [Abstract][Full Text] [Related]
20. The regulatory role of DPP4 in atherosclerotic disease.
Duan L; Rao X; Xia C; Rajagopalan S; Zhong J
Cardiovasc Diabetol; 2017 Jun; 16(1):76. PubMed ID: 28619058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
